Skip to content

Released Jul 16, 2026, after the close

10-Q filed Jul 21, 2026, 21 days after period end · 0001035267-26-000058

Q2 2026 · 10-Q
Revenue$2.89B+18.5% vs Q2 2025+4.4% vs Q1 2026
Net Income$818.10M+24.3% vs Q2 2025−0.4% vs Q1 2026
EPS Diluted$2.29+26.5% vs Q2 2025+0.4% vs Q1 2026
Gross Profit$1,960,400,000+21.2%
Operating Income$971,900,000+30.7%
Operating Cash Flowderived$1,061,000,000+48.3%
Free Cash Flowderived$948,400,000+69.3%
Margins · derived
Gross margin67.8%+1.5 pt vs Q2 2025
Operating margin33.6%+3.1 pt vs Q2 2025
Net margin28.3%+1.3 pt vs Q2 2025

What the release said

Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended June 30, 2026.

Intuitive announced financial results for the quarter ended June 30, 2026.1

Second quarter 2026 revenue was $2.89 billion, GAAP net income was $818 million, and non-GAAP net income was $1.00 billion.234

The Company placed 468 da Vinci surgical systems and 55 Ion endoluminal systems, and its installed bases reached 11,710 and 1,096 systems, respectively, as of June 30, 2026.56

The Company repurchased 0.9 million shares for $0.38 billion and ended the quarter with $8.63 billion in cash, cash equivalents, and investments.78

Revenue
$2.89 billion Second quarter 2026; increased 19%, compared with $2.44 billion in the second quarter of 2025.2
GAAP net income attributable to Intuitive Surgical, Inc.
$818 million Second quarter 2026; compared with $658 million in the second quarter of 2025.3
GAAP diluted net income per share
$2.29 Second quarter 2026; compared with $1.81 per diluted share in the second quarter of 2025.3
Non-GAAP net income attributable to Intuitive Surgical, Inc.
$1.00 billion Second quarter 2026; compared with $0.80 billion in the second quarter of 2025.4
Common-stock repurchases
$0.38 billion Second quarter of 2026.7
Cash, cash equivalents, and investments
$8.63 billion At the end of the second quarter of 2026.8
Thaler Agent · checked against the filing
Open the reading ›
The release

Same quarter

MetricQ2 2026Q2 2025Q2 2024Q2 2023
Revenue$2.89B$2.44B$2.01B$1.76B
Net Income$818.10M$658.40M$526.90M$420.80M
EPS Diluted$2.29$1.81$1.46$1.18

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Intuitive Surgical Inc · CIK 1035267 · Engraved from SEC EDGAR